Tchaikapharma High Quality Medicines AD (BUL:THQM)

Bulgaria flag Bulgaria · Delayed Price · Currency is BGN · Price in EUR
8.20
-0.25 (-2.96%)
At close: Jul 10, 2026
Market Cap1.58B +4.7%
Revenue (ttm)66.61M +21.4%
Net Income7.40M +45.2%
EPS0.07 +46.4%
Shares Out 101.30M
PE Ratio215.58
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume84
Open7.30
Previous Close8.45
Day's Range7.30 - 8.20
52-Week Range4.42 - 9.04
Beta0.01
Analystsn/a
Price Targetn/a
Earnings DateJul 28, 2026

About BUL:THQM

Tchaikapharma High Quality Medicines AD develops, manufactures, and sells medicines in Bulgaria. It offers anaesthesia, anti-inflammatory and anti-rheumatic, antibiotics, cardiovascular system, digestive system, diabetes and metabolism, nervous system, over-the-counter, respiratory system, oncology, and other medicines. The company was founded in 1999 and is headquartered in Sofia, Bulgaria. Tchaikapharma High Quality Medicines AD operates as a subsidiary of Commercial League Healthcare Group Inc. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 214
Stock Exchange Bulgarian Stock Exchange
Ticker Symbol THQM
Full Company Profile

Financial Performance

In 2025, BUL:THQM's revenue was 32.74 million, an increase of 20.17% compared to the previous year's 27.24 million. Earnings were 3.08 million, an increase of 33.64%.

Financial numbers in EUR Financial Statements